Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
(2015) In Europace 17(2). p.215-221- Abstract
- The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality of Life (HRQoL) and symptom burden of patients at 12 and 24 months.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5040966
- author
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Europace
- volume
- 17
- issue
- 2
- pages
- 215 - 221
- publisher
- Oxford University Press
- external identifiers
-
- pmid:25567068
- wos:000351601600009
- scopus:84922433201
- pmid:25567068
- ISSN
- 1532-2092
- DOI
- 10.1093/europace/euu342
- language
- English
- LU publication?
- yes
- id
- cc7a94dc-67f8-4d48-a478-021b5ff55ed9 (old id 5040966)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25567068?dopt=Abstract
- date added to LUP
- 2016-04-01 10:18:04
- date last changed
- 2022-04-27 20:39:14
@article{cc7a94dc-67f8-4d48-a478-021b5ff55ed9, abstract = {{The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation (RFA) vs. antiarrhythmic drug therapy (AAD) as first-line treatment for patients with PAF. In this substudy, we evaluated the effect of these treatment modalities on the Health-Related Quality of Life (HRQoL) and symptom burden of patients at 12 and 24 months.}}, author = {{Walfridsson, H and Walfridsson, U and Nielsen, J Cosedis and Johannessen, A and Raatikainen, P and Janzon, M and Levin, L A and Aronsson, M and Hindricks, G and Kongstad Rasmussen, Ole and Pehrson, S and Englund, A and Hartikainen, J and Mortensen, L S and Hansen, P S}}, issn = {{1532-2092}}, language = {{eng}}, number = {{2}}, pages = {{215--221}}, publisher = {{Oxford University Press}}, series = {{Europace}}, title = {{Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.}}, url = {{http://dx.doi.org/10.1093/europace/euu342}}, doi = {{10.1093/europace/euu342}}, volume = {{17}}, year = {{2015}}, }